DeepSeek R1 May Beat OpenAI's O1, AI Career Success Predictions, and Sleeping Pills Disrupt Brain Cleaning
Wednesday, 29 January 2025 · 1 min read · Listen to the episode ↗
DeepSeek has launched its R1 model, outperforming OpenAI's O1 in reasoning tasks while being significantly more cost-effective. In the AI landscape, ethical concerns arise as AI facial analysis predicts traits influencing hiring. Additionally, research indicates common sleep medications may impair the brain’s cleansing processes, potentially heightening neurodegenerative disease risks, underscoring the need for better sleep quality assessments.
DeepSeek, a Chinese AI company, has launched DeepSeek R1, an open-source reasoning model that outperforms OpenAI's O1 in benchmarks, solving 79.8% of problems in the 2024 American Invitational Mathematics Examination compared to O1's 79.2%. R1 is also more cost-effective, priced at 14 cents per million tokens versus O1's $7.5, and generates 6.2 times more reasoning tokens on average, making it 4.4 times less expensive for equivalent output. With 671 billion parameters and 37 billion activated per token, R1 enhances efficiency in AI reasoning tasks.
AI-driven facial analysis technology is emerging as a tool for predicting traits such as school rank, job seniority, and compensation, raising ethical concerns regarding bias and privacy in hiring practices. By 2025, AI is projected to replace 85 million jobs globally while creating new opportunities in AI-related fields, necessitating a balance between innovation and the protection of worker rights and privacy.
A study published in Cell indicates that sleep medications like Zolpidem (Ambien) may disrupt the brain's glymphatic system, which is essential for cleansing the brain during sleep. The glymphatic system facilitates the exchange of cerebrospinal fluid, clearing metabolic waste and toxic proteins. The study shows that zolpidem suppresses norepinephrine oscillations by 50%, leading to a 30% reduction in cerebrospinal fluid transport. This disruption could increase the risk of neurodegenerative diseases such as Alzheimer's, highlighting the importance of sleep quality over quantity in future assessments of sleep medications.
This summary was generated from the episode transcript and can contain mistakes.